Create Account | Sign In: Author or Forum

Search Symptoms

CONFERENCE NEWS

ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis

November 21, 2022. 10:31 PM CST.

However, opioids and NSAIDs carry similar cardiovascular, mortality risks for RA patients

Read article

OTHER CONFERENCE NEWS

AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM

November 08, 2022

In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo


AHA: Environmental Exposures Tied to CVD Deaths in the U.S., U.K.

November 07, 2022

Risk-attributable cardiovascular death rate associated with lead exposure higher in the U.S. than the U.K.; opposite pattern seen between the countries for particulate matter exposure


AHA: Vaping Tied to Negative Effects on Cardiovascular Function

November 07, 2022

Increases in BP, heart rate greater; reduction in brachial artery diameter greater; and performance on exercise parameters worse for vapers, smokers compared with controls


AHA: Those With, at Risk for CVD Less Likely to Use Wearables

November 04, 2022

Wearable health device use in the U.S. lower among those older than 65 years, higher among those with higher household income, educational attainment


AHA: Heart Disease Death Rates in U.S. Spiked in 2020

November 04, 2022

Following steady decline from 2010 to 2019, death rates increased in 2020, especially among young adults, non-Hispanic Blacks


AHA: Once-Daily Edoxaban Seems Safe for Pediatric Cardiac Patients

November 04, 2022

Rates of clinically relevant bleeding similar between groups receiving edoxaban or standard-of-care anticoagulation


Once-Weekly Semaglutide Cuts BMI for Teens With Obesity

November 04, 2022

Greater reduction in BMI seen for semaglutide plus lifestyle intervention versus lifestyle intervention alone


Long-Term Outcomes of PCI, CABG Compared for Multivessel CAD

October 05, 2022

Findings for median follow-up of 11.8 years reported from multicenter, randomized, controlled trial terminated early due to slow enrollment


Cerebral Embolic Protection Does Not Prevent Stroke in TAVR

September 30, 2022

No significant impact seen for CEP on incidence of periprocedural stroke among patients with aortic stenosis undergoing transfemoral TAVR


Quality of YouTube Medical Videos Often Poor for Patient Education

September 28, 2022

Quality of YouTube videos for patients considering an implantable cardioverter defibrillator found to be highly variable, poor overall


Traffic-Related Air Pollution May Impact Women More

September 20, 2022

Effects on plasma proteins known to play a role in inflammation, oxidative stress, cardiovascular disease greater in women than in men


Efficacy, Safety of Extravascular ICD Explored

September 19, 2022

The extravascular implantable cardioverter-defibrillator system is premarket and has not yet been approved by the FDA


Daily Timing of Antihypertensives Does Not Impact Effectiveness

September 16, 2022

Evening dosing of blood pressure medication no better than morning dosing


Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19

September 16, 2022

However, no significant difference seen in efficacy or safety outcomes for clopidogrel versus no antiplatelet therapy


Incident Cardiovascular Disease Risk Up With Autoimmune Disease

September 16, 2022

Risk increased progressively with the number of autoimmune diseases present and with younger age